Skadden and NautaDutilh N.V. have advised CureVac. Covington & Burling LLP, Hengeler Mueller Partnerschaft von Rechtsanwälten mbB and Loyens & Loeff N.V. have advised BioNTech. BioNTech...
BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction
BioNTech’s Acquisition of InstaDeep
CMS has advised the founders and other investors of InstaDeep on the deal. Latham & Watkins has advised Chimera Abu Dhabi on the sale. Choate and...
BioNTech’s Research Collaboration Agreement with Ryvu Therapeutics
McDermott Will & Emery and CK Legal advised Ryvu Therapeutics S.A., while Osborne Clarke and CMS Poland advised BioNTech on the deal. Ryvu Therapeutics S.A., a...
BioNTech’s Acquisition of a GMP-Certified Manufacturing Facility From Novartis
CMS advised BioNTech SE (Nasdaq: BNTX) on the deal. BioNTech SE (Nasdaq: BNTX), a German biotechnology company, acquired a GMP-certified manufacturing facility in Singapore from Novartis...




























